BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10567554)

  • 1. Mismatch repair processing of carcinogen-DNA adducts triggers apoptosis.
    Wu J; Gu L; Wang H; Geacintov NE; Li GM
    Mol Cell Biol; 1999 Dec; 19(12):8292-301. PubMed ID: 10567554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo modulations of benzo[c]phenanthrene-DNA adducts by DNA mismatch repair system.
    Wu J; Zhu BB; Yu J; Zhu H; Qiu L; Kindy MS; Gu L; Seidel A; Li GM
    Nucleic Acids Res; 2003 Nov; 31(22):6428-34. PubMed ID: 14602900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress inactivates the human DNA mismatch repair system.
    Chang CL; Marra G; Chauhan DP; Ha HT; Chang DK; Ricciardiello L; Randolph A; Carethers JM; Boland CR
    Am J Physiol Cell Physiol; 2002 Jul; 283(1):C148-54. PubMed ID: 12055083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
    Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
    Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.
    Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA
    Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human MutSalpha specifically binds to DNA containing aminofluorene and acetylaminofluorene adducts.
    Li GM; Wang H; Romano LJ
    J Biol Chem; 1996 Sep; 271(39):24084-8. PubMed ID: 8798646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha.
    Genschel J; Littman SJ; Drummond JT; Modrich P
    J Biol Chem; 1998 Jul; 273(31):19895-901. PubMed ID: 9677427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems.
    Mu D; Tursun M; Duckett DR; Drummond JT; Modrich P; Sancar A
    Mol Cell Biol; 1997 Feb; 17(2):760-9. PubMed ID: 9001230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mismatch repair in DNA damage-induced apoptosis.
    Li GM
    Oncol Res; 1999; 11(9):393-400. PubMed ID: 10821533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human mismatch repair and G*T mismatch binding by hMutSalpha in vitro is inhibited by adriamycin, actinomycin D, and nogalamycin.
    Larson ED; Drummond JT
    J Biol Chem; 2001 Mar; 276(13):9775-83. PubMed ID: 11134041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional overlap in mismatch repair by human MSH3 and MSH6.
    Umar A; Risinger JI; Glaab WE; Tindall KR; Barrett JC; Kunkel TA
    Genetics; 1998 Apr; 148(4):1637-46. PubMed ID: 9560383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents.
    Humbert O; Fiumicino S; Aquilina G; Branch P; Oda S; Zijno A; Karran P; Bignami M
    Carcinogenesis; 1999 Feb; 20(2):205-14. PubMed ID: 10069455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific binding of human MSH2.MSH6 mismatch-repair protein heterodimers to DNA incorporating thymine- or uracil-containing UV light photoproducts opposite mismatched bases.
    Wang H; Lawrence CW; Li GM; Hays JB
    J Biol Chem; 1999 Jun; 274(24):16894-900. PubMed ID: 10358035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mismatch repair proteins are activators of toxic responses to chromium-DNA damage.
    Peterson-Roth E; Reynolds M; Quievryn G; Zhitkovich A
    Mol Cell Biol; 2005 May; 25(9):3596-607. PubMed ID: 15831465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of DNA mismatch repair proteins with human exonuclease I.
    Schmutte C; Sadoff MM; Shim KS; Acharya S; Fishel R
    J Biol Chem; 2001 Aug; 276(35):33011-8. PubMed ID: 11427529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of human MutSalpha and MutSbeta complexes in yeast.
    Clark AB; Cook ME; Tran HT; Gordenin DA; Resnick MA; Kunkel TA
    Nucleic Acids Res; 1999 Feb; 27(3):736-42. PubMed ID: 9889267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents.
    Christmann M; Kaina B
    J Biol Chem; 2000 Nov; 275(46):36256-62. PubMed ID: 10954713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of DNA mismatch repair in folate deficiency-induced apoptosis small star, filled.
    Gu L; Wu J; Qiu L; Jennings CD; Li GM
    J Nutr Biochem; 2002 Jun; 13(6):355-363. PubMed ID: 12088801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of DNA mismatch repair in platinum drug resistance.
    Fink D; Nebel S; Aebi S; Zheng H; Cenni B; Nehmé A; Christen RD; Howell SB
    Cancer Res; 1996 Nov; 56(21):4881-6. PubMed ID: 8895738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.